71 related articles for article (PubMed ID: 28436606)
1. Early and late adverse effects of radioiodine for pediatric differentiated thyroid cancer.
Albano D; Bertagna F; Panarotto MB; Giubbini R
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28436606
[TBL] [Abstract][Full Text] [Related]
2. Bone metastases from differentiated thyroid cancer: characteristics and prognostic factors in a multicenter series.
Piñar-Gutiérrez A; Romero-Lluch AR; Dueñas-Disotuar S; de Lara-Rodríguez I; Gálvez-Moreno MÁ; Martín-Hernández T; García-Alemán J; Martínez-de Pinillos G; Navarro-González E
Eur Thyroid J; 2023 Oct; 12(5):. PubMed ID: 37493475
[TBL] [Abstract][Full Text] [Related]
3. Seeking Optimal Management for Radioactive Iodine Therapy-induced Adverse Effects.
Charalambous A
Asia Pac J Oncol Nurs; 2017; 4(4):319-322. PubMed ID: 28966960
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal Side Effects of the Radioiodine Therapy for the Patients with Differentiated Thyroid Carcinoma Two Days after Prescription.
Pashnehsaz M; Takavar A; Izadyar S; Zakariaee SS; Mahmoudi M; Paydar R; Geramifar P
World J Nucl Med; 2016 Sep; 15(3):173-8. PubMed ID: 27651737
[TBL] [Abstract][Full Text] [Related]
5. The potential role of reprogrammed glucose metabolism: an emerging actionable codependent target in thyroid cancer.
Duan SL; Wu M; Zhang ZJ; Chang S
J Transl Med; 2023 Oct; 21(1):735. PubMed ID: 37853445
[TBL] [Abstract][Full Text] [Related]
6. Benefits of basil tea for patients with differentiated thyroid cancer during radioiodine therapy: A randomized controlled trial.
Nomura K; Nakayama M; Okizaki A
Heliyon; 2023 Oct; 9(10):e20691. PubMed ID: 37829808
[TBL] [Abstract][Full Text] [Related]
7. A Systematic Review and Meta-Analysis of Subsequent Malignant Neoplasm Risk After Radioactive Iodine Treatment of Thyroid Cancer.
Yu CY; Saeed O; Goldberg AS; Farooq S; Fazelzad R; Goldstein DP; Tsang RW; Brierley JD; Ezzat S; Thabane L; Goldsmith CH; Sawka AM
Thyroid; 2018 Dec; 28(12):1662-1673. PubMed ID: 30370820
[No Abstract] [Full Text] [Related]
8. Differentiated thyroid cancer theranostics: radioiodine and beyond.
Choudhury PS; Gupta M
Br J Radiol; 2018 Nov; 91(1091):20180136. PubMed ID: 30260232
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic prednisolone for the prevention of early and intermediate adverse effects of radioactive iodine therapy in patients with thyroid cancer: study protocol for a single-centre, phase II/III, randomized, double-blinded, placebo-controlled clinical trial.
Jayarajah U; Wijekoon M; Seneviratne SA
Trials; 2020 Sep; 21(1):812. PubMed ID: 32993815
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Effects of Radioiodine Treatment on Female Fertility in Survivors of Childhood Differentiated Thyroid Carcinoma.
Nies M; Cantineau AEP; Arts EGJM; van den Berg MH; van Leeuwen FE; Muller Kobold AC; Klein Hesselink MS; Burgerhof JGM; Brouwers AH; van Dam EWCM; Havekes B; van den Heuvel-Eibrink MM; Corssmit EPM; Kremer LCM; Netea-Maier RT; van der Pal HJH; Peeters RP; Plukker JTM; Ronckers CM; van Santen HM; van der Horst-Schrivers ANA; Tissing WJE; Bocca G; van Dulmen-den Broeder E; Links TP
Thyroid; 2020 Aug; 30(8):1169-1176. PubMed ID: 32079487
[No Abstract] [Full Text] [Related]
11. Serum anti-Müllerian hormone is lower in patients with multiple radioiodine dose for treatment of pediatric thyroid cancer.
Barreto MCA; Treistman N; Cavalcante LBCP; Bulzico D; de Andrade FA; Corbo R; Alves Junior PAG; Vaisman F
Eur Thyroid J; 2024 Apr; 13(2):. PubMed ID: 38290210
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary injury after radioactive iodine therapy in pediatric papillary thyroid cancer: a case report.
Halada S; Leftin Dobkin S; Baran JA; Sisko L; Robbins SL; Rapp JB; Young LR; Bauer AJ
Horm Res Paediatr; 2023 Nov; ():. PubMed ID: 37956658
[TBL] [Abstract][Full Text] [Related]
13. Development of a pediatric differentiated thyroid carcinoma registry within the EuRRECa project: rationale and protocol.
Clement SC; Visser WE; Lebbink CA; Albano D; Claahsen-van der Grinten HL; Czarniecka A; Dias RP; Dierselhuis MP; Dzivite-Krisane I; Elisei R; Garcia-Burillo A; Izatt L; Kanaka-Gantenbein C; Krude H; Lamartina L; Lorenz K; Luster M; Navardauskaitė R; Negre Busó M; Newbold K; Peeters RP; Pellegriti G; Piccardo A; Priego AL; Redlich A; de Sanctis L; Sobrinho-Simões M; van Trotsenburg ASP; Verburg FA; Vriens M; Links TP; Ahmed SF; van Santen HM
Endocr Connect; 2023 Mar; 12(3):. PubMed ID: 37931414
[TBL] [Abstract][Full Text] [Related]
14. The association between the interval of radioiodine treatment and treatment response, and side effects in patients with lung metastases from differentiated thyroid cancer.
Wang H; Shi L; Huang R; Liu B; Tian R
Front Endocrinol (Lausanne); 2023; 14():1117001. PubMed ID: 37324277
[TBL] [Abstract][Full Text] [Related]
15. 2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma.
Lebbink CA; Links TP; Czarniecka A; Dias RP; Elisei R; Izatt L; Krude H; Lorenz K; Luster M; Newbold K; Piccardo A; Sobrinho-Simões M; Takano T; Paul van Trotsenburg AS; Verburg FA; van Santen HM
Eur Thyroid J; 2022 Dec; 11(6):. PubMed ID: 36228315
[TBL] [Abstract][Full Text] [Related]
16. Imaging of pediatric thyroid tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.
Squires JH; Martinez-Rios C; Davis JC; Dietz KR; Epelman MS; Lai HA; Lim-Dunham JE; McDaniel JD; Mhlanga JC; Pandit-Taskar N; Parisi MT; Trout AT; Weidman EK; Alazraki AL
Pediatr Blood Cancer; 2023 Jun; 70 Suppl 4(Suppl 4):e29957. PubMed ID: 36165682
[TBL] [Abstract][Full Text] [Related]
17. Strategies for Radioiodine Treatment: What's New.
Sparano C; Moog S; Hadoux J; Dupuy C; Al Ghuzlan A; Breuskin I; Guerlain J; Hartl D; Baudin E; Lamartina L
Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954463
[TBL] [Abstract][Full Text] [Related]
18. Pathological Analysis of Encased Resected Recurrent Nerves in Locally Invasive Thyroid Cancer.
Dahan A; Al Ghuzlan A; Chehab R; Guerlain J; Breuskin I; Garcia C; Lamartina L; Hadoux J; Baudin E; Hartl DM
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740626
[TBL] [Abstract][Full Text] [Related]
19. Larotrectinib Before Initial Radioactive Iodine Therapy in Pediatric TRK Fusion-Positive Papillary Thyroid Carcinoma: Time to Reconsider the Treatment Paradigm for Distantly Metastatic Disease?
Waguespack SG; Tewari SO; Busaidy NL; Zafereo ME
JCO Precis Oncol; 2022 Apr; 6():e2100467. PubMed ID: 35420905
[No Abstract] [Full Text] [Related]
20. Association Between Radioactive Iodine Treatment for Pediatric and Young Adulthood Differentiated Thyroid Cancer and Risk of Second Primary Malignancies.
Pasqual E; Schonfeld S; Morton LM; Villoing D; Lee C; Berrington de Gonzalez A; Kitahara CM
J Clin Oncol; 2022 May; 40(13):1439-1449. PubMed ID: 35044839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
